Literature DB >> 30510082

Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics.

Maoxiang Qian1,2,3, Heng Xu4, Virginia Perez-Andreu1,5, Kathryn G Roberts6, Hui Zhang1,7, Wenjian Yang1, Shouyue Zhang4, Xujie Zhao1, Colton Smith1, Meenakshi Devidas8, Julie M Gastier-Foster9,10,11, Elizabeth Raetz12, Eric Larsen13, Esteban G Burchard14, Naomi Winick15, W Paul Bowman16, Paul L Martin17, Michael Borowitz18, Brent Wood19, Federico Antillon-Klussmann20, Ching-Hon Pui21,22, Charles G Mullighan6,22, William E Evans1,22, Stephen P Hunger23,24, Mary V Relling1,22, Mignon L Loh25,26, Jun J Yang1,21,22.   

Abstract

Acute lymphoblastic leukemia (ALL) is the most common malignancy in children. Characterized by high levels of Native American ancestry, Hispanics are disproportionally affected by this cancer with high incidence and inferior survival. However, the genetic basis for this disparity remains poorly understood because of a paucity of genome-wide investigation of ALL in Hispanics. Performing a genome-wide association study (GWAS) in 940 Hispanic children with ALL and 681 ancestry-matched non-ALL controls, we identified a novel susceptibility locus in the ERG gene (rs2836365; P = 3.76 × 10-8; odds ratio [OR] = 1.56), with independent validation (P = .01; OR = 1.43). Imputation analyses pointed to a single causal variant driving the association signal at this locus overlapping with putative regulatory DNA elements. The effect size of the ERG risk variant rose with increasing Native American genetic ancestry. The ERG risk genotype was underrepresented in ALL with the ETV6-RUNX1 fusion (P < .0005) but enriched in the TCF3-PBX1 subtype (P < .05). Interestingly, ALL cases with germline ERG risk alleles were significantly less likely to have somatic ERG deletion (P < .05). Our results provide novel insights into genetic predisposition to ALL and its contribution to racial disparity in this cancer.
© 2019 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30510082      PMCID: PMC6376278          DOI: 10.1182/blood-2018-07-862946

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   25.476


  25 in total

Review 1.  Treatment of acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui; William E Evans
Journal:  N Engl J Med       Date:  2006-01-12       Impact factor: 91.245

2.  Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.

Authors:  Jinghui Zhang; Kelly McCastlain; Hiroki Yoshihara; Beisi Xu; Yunchao Chang; Michelle L Churchman; Gang Wu; Yongjin Li; Lei Wei; Ilaria Iacobucci; Yu Liu; Chunxu Qu; Ji Wen; Michael Edmonson; Debbie Payne-Turner; Kerstin B Kaufmann; Shin-Ichiro Takayanagi; Erno Wienholds; Esmé Waanders; Panagiotis Ntziachristos; Sofia Bakogianni; Jingjing Wang; Iannis Aifantis; Kathryn G Roberts; Jing Ma; Guangchun Song; John Easton; Heather L Mulder; Xiang Chen; Scott Newman; Xiaotu Ma; Michael Rusch; Pankaj Gupta; Kristy Boggs; Bhavin Vadodaria; James Dalton; Yanling Liu; Marcus L Valentine; Li Ding; Charles Lu; Robert S Fulton; Lucinda Fulton; Yashodhan Tabib; Kerri Ochoa; Meenakshi Devidas; Deqing Pei; Cheng Cheng; Jun Yang; William E Evans; Mary V Relling; Ching-Hon Pui; Sima Jeha; Richard C Harvey; I-Ming L Chen; Cheryl L Willman; Guido Marcucci; Clara D Bloomfield; Jessica Kohlschmidt; Krzysztof Mrózek; Elisabeth Paietta; Martin S Tallman; Wendy Stock; Matthew C Foster; Janis Racevskis; Jacob M Rowe; Selina Luger; Steven M Kornblau; Sheila A Shurtleff; Susana C Raimondi; Elaine R Mardis; Richard K Wilson; John E Dick; Stephen P Hunger; Mignon L Loh; James R Downing; Charles G Mullighan
Journal:  Nat Genet       Date:  2016-10-24       Impact factor: 38.330

3.  Trends in childhood cancer incidence in the U.S. (1992-2004).

Authors:  Amy M Linabery; Julie A Ross
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

4.  The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells.

Authors:  Stephen J Loughran; Elizabeth A Kruse; Douglas F Hacking; Carolyn A de Graaf; Craig D Hyland; Tracy A Willson; Katya J Henley; Sarah Ellis; Anne K Voss; Donald Metcalf; Douglas J Hilton; Warren S Alexander; Benjamin T Kile
Journal:  Nat Immunol       Date:  2008-05-25       Impact factor: 25.606

5.  Germline genomic variants associated with childhood acute lymphoblastic leukemia.

Authors:  Lisa R Treviño; Wenjian Yang; Deborah French; Stephen P Hunger; William L Carroll; Meenakshi Devidas; Cheryl Willman; Geoffrey Neale; James Downing; Susana C Raimondi; Ching-Hon Pui; William E Evans; Mary V Relling
Journal:  Nat Genet       Date:  2009-08-16       Impact factor: 38.330

6.  Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse.

Authors:  Virginia Perez-Andreu; Kathryn G Roberts; Richard C Harvey; Wenjian Yang; Cheng Cheng; Deqing Pei; Heng Xu; Julie Gastier-Foster; Shuyu E; Joshua Yew-Suang Lim; I-Ming Chen; Yiping Fan; Meenakshi Devidas; Michael J Borowitz; Colton Smith; Geoffrey Neale; Esteban G Burchard; Dara G Torgerson; Federico Antillon Klussmann; Cesar Rolando Najera Villagran; Naomi J Winick; Bruce M Camitta; Elizabeth Raetz; Brent Wood; Feng Yue; William L Carroll; Eric Larsen; W Paul Bowman; Mignon L Loh; Michael Dean; Deepa Bhojwani; Ching-Hon Pui; William E Evans; Mary V Relling; Stephen P Hunger; Cheryl L Willman; Charles G Mullighan; Jun J Yang
Journal:  Nat Genet       Date:  2013-10-20       Impact factor: 38.330

7.  Treating childhood acute lymphoblastic leukemia without cranial irradiation.

Authors:  Ching-Hon Pui; Dario Campana; Deqing Pei; W Paul Bowman; John T Sandlund; Sue C Kaste; Raul C Ribeiro; Jeffrey E Rubnitz; Susana C Raimondi; Mihaela Onciu; Elaine Coustan-Smith; Larry E Kun; Sima Jeha; Cheng Cheng; Scott C Howard; Vickey Simmons; Amy Bayles; Monika L Metzger; James M Boyett; Wing Leung; Rupert Handgretinger; James R Downing; William E Evans; Mary V Relling
Journal:  N Engl J Med       Date:  2009-06-25       Impact factor: 91.245

Review 8.  The influence of race and ethnicity on the biology of cancer.

Authors:  Brian E Henderson; Norman H Lee; Victoria Seewaldt; Hongbing Shen
Journal:  Nat Rev Cancer       Date:  2012-08-02       Impact factor: 60.716

9.  Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution.

Authors:  M Ryan Corces; Jason D Buenrostro; Beijing Wu; Peyton G Greenside; Steven M Chan; Julie L Koenig; Michael P Snyder; Jonathan K Pritchard; Anshul Kundaje; William J Greenleaf; Ravindra Majeti; Howard Y Chang
Journal:  Nat Genet       Date:  2016-08-15       Impact factor: 38.330

10.  Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia.

Authors:  Jayaram Vijayakrishnan; James Studd; Peter Broderick; Ben Kinnersley; Amy Holroyd; Philip J Law; Rajiv Kumar; James M Allan; Christine J Harrison; Anthony V Moorman; Ajay Vora; Eve Roman; Sivaramakrishna Rachakonda; Sally E Kinsey; Eamonn Sheridan; Pamela D Thompson; Julie A Irving; Rolf Koehler; Per Hoffmann; Markus M Nöthen; Stefanie Heilmann-Heimbach; Karl-Heinz Jöckel; Douglas F Easton; Paul D P Pharaoh; Alison M Dunning; Julian Peto; Frederico Canzian; Anthony Swerdlow; Rosalind A Eeles; ZSofia Kote-Jarai; Kenneth Muir; Nora Pashayan; Mel Greaves; Martin Zimmerman; Claus R Bartram; Martin Schrappe; Martin Stanulla; Kari Hemminki; Richard S Houlston
Journal:  Nat Commun       Date:  2018-04-09       Impact factor: 14.919

View more
  19 in total

Review 1.  Genetic defects in hematopoietic transcription factors and predisposition to acute lymphoblastic leukemia.

Authors:  Yoshihiro Gocho; Jun J Yang
Journal:  Blood       Date:  2019-07-16       Impact factor: 22.113

2.  Clinical Outcomes of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia in a County Hospital System.

Authors:  Effrosyni Apostolidou; Curtis Lachowiez; Harinder S Juneja; Wei Qiao; Onyebuchi Ononogbu; Courtney Nicole Miller-Chism; Mark Udden; Hilary Ma; Martha Pritchett Mims
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2021-07-04

3.  Genetic determinants of blood-cell traits influence susceptibility to childhood acute lymphoblastic leukemia.

Authors:  Linda Kachuri; Soyoung Jeon; Andrew T DeWan; Catherine Metayer; Xiaomei Ma; John S Witte; Charleston W K Chiang; Joseph L Wiemels; Adam J de Smith
Journal:  Am J Hum Genet       Date:  2021-08-31       Impact factor: 11.043

Review 4.  Diversity upon diversity: linking DNA double-strand break repair to blood cancer health disparities.

Authors:  Jason N Sterrenberg; Melissa L Folkerts; Valeria Rangel; Sarah Eugenie Lee; Nicholas R Pannunzio
Journal:  Trends Cancer       Date:  2022-01-31

5.  Leveraging Genome and Phenome-Wide Association Studies to Investigate Genetic Risk of Acute Lymphoblastic Leukemia.

Authors:  Eleanor C Semmes; Jayaram Vijayakrishnan; Chenan Zhang; Jillian H Hurst; Richard S Houlston; Kyle M Walsh
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

Review 6.  Infectious triggers and novel therapeutic opportunities in childhood B cell leukaemia.

Authors:  Cesar Cobaleda; Carolina Vicente-Dueñas; Isidro Sanchez-Garcia
Journal:  Nat Rev Immunol       Date:  2021-02-08       Impact factor: 53.106

Review 7.  Advances in germline predisposition to acute leukaemias and myeloid neoplasms.

Authors:  Jeffery M Klco; Charles G Mullighan
Journal:  Nat Rev Cancer       Date:  2020-12-16       Impact factor: 60.716

8.  Cancer Progress and Priorities: Childhood Cancer.

Authors:  Philip J Lupo; Logan G Spector
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-06       Impact factor: 4.090

Review 9.  The Biology of B-Progenitor Acute Lymphoblastic Leukemia.

Authors:  Kathryn G Roberts; Charles G Mullighan
Journal:  Cold Spring Harb Perspect Med       Date:  2020-07-01       Impact factor: 5.159

10.  Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.

Authors:  Austin L Brown; Adam J de Smith; Vincent U Gant; Wenjian Yang; Michael E Scheurer; Kyle M Walsh; Jonathan M Chernus; Noah A Kallsen; Shanna A Peyton; Gareth E Davies; Erik A Ehli; Naomi Winick; Nyla A Heerema; Andrew J Carroll; Michael J Borowitz; Brent L Wood; William L Carroll; Elizabeth A Raetz; Eleanor Feingold; Meenakshi Devidas; Lisa F Barcellos; Helen M Hansen; Libby Morimoto; Alice Y Kang; Ivan Smirnov; Jasmine Healy; Caroline Laverdière; Daniel Sinnett; Jeffrey W Taub; Jillian M Birch; Pamela Thompson; Logan G Spector; Maria S Pombo-de-Oliveira; Andrew T DeWan; Charles G Mullighan; Stephen P Hunger; Ching-Hon Pui; Mignon L Loh; Michael E Zwick; Catherine Metayer; Xiaomei Ma; Beth A Mueller; Stephanie L Sherman; Joseph L Wiemels; Mary V Relling; Jun J Yang; Philip J Lupo; Karen R Rabin
Journal:  Blood       Date:  2019-10-10       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.